Medical Weight Loss
Medically supervised weight management with a provider who has time for you.
Ages 13+ · Insurance & self-pay options
We review your health history, goals, and lab results, then build a plan with you and adjust it at regular follow-up visits.
Our approach combines medical assessment, nutritional guidance, lifestyle support, and — when clinically appropriate — FDA-approved medication options. We provide ongoing monitoring so you can build lasting habits.
Two Ways to Get Started
Choose the path that works for your situation — we'll help you decide during your consultation.
Using Insurance
We start with a medical visit billed to your insurance. If your plan covers weight-loss medication, we help with the approval process.
Some plans require a structured lifestyle program before they cover medication. We'll walk you through what's needed.
Self-Pay
For patients whose plan doesn't cover weight-loss medication, or who prefer a simpler path.
Clear pricing for visits and follow-up. Medication is prescribed when it's medically appropriate for you.
Call for PricingYour Plan, End to End
Consultation
A full health review before starting any treatment.
FDA-Approved Medications
When appropriate for you, based on clinical evaluation.
Nutrition & Activity Guidance
Practical steps that fit your life.
Regular Follow-Up
In-person or telehealth check-ins to track progress and side effects.
Teens (Ages 13–17)
A parent or guardian must attend visits. Treatment plans follow guidelines for adolescents.
We take extra time with teen patients to ensure goals are realistic, sustainable, and aligned with healthy growth.
Medication Pathways & Estimated Costs
| Medication Pathway | Form | Dosing | Estimated Medication Cost | Insurance / Savings | Best Fit |
|---|---|---|---|---|---|
| Compounded Semaglutide | Injection | Weekly | $70–$250/month | Typically not covered | Lower-cost self-pay option when clinically appropriate |
| Compounded Tirzepatide | Injection | Weekly | $140–$600/month | Typically not covered | Self-pay tirzepatide-based option when clinically appropriate |
| Foundayo™ (Orforglipron) | Tablet | Daily | $149–$349/month | May vary by program/coverage | Patients who prefer oral medication |
| Zepbound® | Injection | Weekly | $299–$449/month | May be as low as $25 if eligible | FDA-approved tirzepatide option |
| Wegovy® Oral | Tablet | Daily | $149–$299/month | May be as low as $25 if eligible | Patients who prefer pills and can follow dosing instructions |
| Wegovy® Injection | Injection | Weekly | $199–$349/month | May be as low as $25 if eligible | FDA-approved semaglutide injectable option |
Pricing Notice
Medical Notice
Compounded Medication Notice
About Each Medication Pathway
Compounded semaglutide may be considered for patients seeking a lower-cost self-pay pathway when clinically appropriate. Typically prescribed as a weekly injection and sent to a licensed compounding pharmacy.
Compounded medications are not FDA-approved and are not usually covered by insurance. Medication cost, pharmacy fees, shipping, delivery, and supply availability are handled directly between the patient and the dispensing pharmacy.
Key considerations:- Weekly injectable medication
- Self-pay pathway
- Requires self-injection
- Typically not insurance-covered
- Pharmacy pricing and availability may vary
- Not FDA-approved
Compounded tirzepatide may be considered for patients seeking a tirzepatide-based self-pay pathway when clinically appropriate. Typically prescribed as a weekly injection; medication costs may be higher at higher doses.
Compounded medications are not FDA-approved and are not usually covered by insurance. Medication cost, pharmacy fees, shipping, delivery, and supply availability are handled directly between the patient and the dispensing pharmacy.
Key considerations:- Weekly injectable medication
- Self-pay pathway
- Requires self-injection
- Cost may increase at higher doses
- Typically not insurance-covered
- Pharmacy pricing and availability may vary
- Not FDA-approved
An oral GLP-1 medication pathway may be considered for patients who prefer a tablet instead of an injection, when clinically appropriate and available. Oral medication options may appeal to patients who travel frequently, dislike needles, or prefer a daily routine.
Some oral medications may have specific dosing instructions, including timing around food, water, or other medications. Coverage, pricing, pharmacy availability, and eligibility vary by medication and program.
Key considerations:- Daily tablet option
- May be preferred by patients avoiding injections
- Dosing instructions may be strict depending on medication
- Coverage and eligibility vary
- Pharmacy availability may vary
Zepbound® is an FDA-approved tirzepatide medication that may be considered for eligible patients seeking a branded weekly injectable option. It works through GIP and GLP-1 pathways and may be prescribed through a retail, mail-order, or manufacturer-supported pharmacy pathway depending on eligibility and coverage.
Insurance coverage, prior authorization requirements, savings-card eligibility, final medication pricing, and pharmacy availability vary.
Key considerations:- FDA-approved branded medication
- Weekly injection
- May require refrigeration
- Insurance coverage may require prior authorization
- Savings-card eligibility may vary
- Final cost is determined by pharmacy, insurance, or manufacturer program
A semaglutide oral pathway may be considered for patients who prefer a tablet option and can follow medication-specific dosing instructions. Some oral semaglutide options require fasting or careful timing around food, beverages, and other medications to support absorption.
Coverage, pricing, pharmacy availability, manufacturer program eligibility, and final out-of-pocket cost vary.
Key considerations:- Daily tablet option
- May be preferred by patients avoiding injections
- May require fasting instructions
- Coverage and savings eligibility vary
- Pharmacy availability may vary
Wegovy® is an FDA-approved semaglutide medication that may be considered for eligible patients seeking a branded weekly injectable option. It may be prescribed through a retail, mail-order, or manufacturer-supported pharmacy pathway depending on eligibility and coverage.
Insurance coverage, prior authorization requirements, savings-card eligibility, final medication pricing, and pharmacy availability vary.
Key considerations:- FDA-approved branded medication
- Weekly injection
- May require refrigeration
- Insurance coverage may require prior authorization
- Savings-card eligibility may vary
- Final cost is determined by pharmacy, insurance, or manufacturer program
Frequently Asked Questions
Treatment Questions
Costs & Logistics
Tirzepatide options: range from $299 to $1,250+ depending on dose and pathway.
Exact pricing depends on the specific medication, dose, and whether brand-name or compounded.
Ready to Start Your Weight-Loss Journey?
Schedule your consultation and let's build a plan that works for your health and your life.